Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma
dc.contributor.author | Oduor, Cliff I | |
dc.contributor.author | Chelimo, Kiprotich | |
dc.contributor.author | Ouma, Collins | |
dc.contributor.author | Mulama, David H | |
dc.contributor.author | Foley, Joslyn | |
dc.contributor.author | Vulule, John | |
dc.contributor.author | Bailey, Jeffrey A | |
dc.contributor.author | Moormann, Ann M | |
dc.date.accessioned | 2018-01-22T12:36:08Z | |
dc.date.available | 2018-01-22T12:36:08Z | |
dc.date.issued | 2014-09-03 | |
dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/180 | |
dc.description.abstract | Overexpression of interleukin-6 (IL-6) and IL-10 in endemic Burkitt lymphoma (eBL) may facilitate tumorigenesis by providing a permissive cytokine milieu. Promoter polymorphisms influence interindividual differences in cytokine production. We hypothesized that children genetically predisposed for elevated cytokine levels may be more susceptible to eBL. Using case-control samples from western Kenya consisting of 117 eBL cases and 88 ethnically matched healthy controls, we tested for the association between eBL risk and IL-10 (rs1800896, rs1800871, and rs1800872) and IL-6 (rs1800795) promoter single nucleotide polymorphisms (SNPs) as well as IL-10 promoter haplotypes. In addition, the association between these variants and Epstein Barr Virus (EBV) load was examined. Results showed that selected IL-10 and IL-6 promoter SNPs and IL-10 promoter … | en_US |
dc.publisher | The American Society of Tropical Medicine and Hygiene | en_US |
dc.title | Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma | en_US |
dc.type | Article | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |